Meta-Analysis on Insulin Resistance Score and Gestational Diabetes Risk

A systematic review and meta-analysis of 6 studies involving 93,995 pregnant women evaluates the association between the Metabolic Score for Insulin Resistance (METS-IR) and gestational diabetes mellitus (GDM). The analysis, conducted by Bo Dai and published on figshare in 2026, found a pooled odds ratio of 2.53 for GDM risk in the highest versus lowest METS-IR category. The document includes subgroup analyses by country, study design, and sample size.

Use Cases

• Assessing the predictive value of METS-IR for GDM risk based on the pooled odds ratio
• Conducting subgroup analyses on GDM risk factors by country and study design as described in the results
• Validating non-invasive insulin resistance markers for early pregnancy screening as suggested in the conclusion

Strengths

• The meta-analysis includes data from 93,995 pregnant women across 6 studies
• Results include specific pooled odds ratios (e.g., 2.53) with confidence intervals and heterogeneity statistics (I²=57%)
• Subgroup analyses are provided for Chinese and American populations, prospective/retrospective cohorts, and sample size categories

Limitations

• The dataset is a 30.4 KB DOCX document containing a research paper, not a structured data file
• Column-level documentation is absent; field semantics must be inferred after download
• The data reflects findings from a systematic review up to March 2026 and may have inherent selection bias from the included studies

Provenance

Source

Bo Dai

Collection Method

Systematic review and meta-analysis of studies from PubMed, Embase, Web of Science, and Cochrane Library.

Time Range

Studies included up to March 2026.

Freshness

Last updated 2026-05-28 06:18:21

Geography

Studies included Chinese and American populations.